Literature DB >> 9640190

Diabetic retinopathy in Down's syndrome.

T Fulcher1, M Griffin, S Crowley, R Firth, R Acheson, N O'Meara.   

Abstract

AIM: To determine the prevalence of diabetic retinopathy in patients with Down's syndrome and diabetes mellitus.
METHODS: Nine patients with Down's syndrome and diabetes mellitus were assessed. Factors recorded included type and duration of diabetes, level of diabetic control, blood pressure, urinalysis, and results of ophthalmological examination.
RESULTS: The duration of diabetes ranged from 8 to 41 years (mean 17.6 years). All had satisfactory glycaemic control and blood pressure measurements on the low side of normal (mean 106.6/70 mm Hg). One patient had early background diabetic retinopathy. The remainder had no evidence of diabetic retinopathy.
CONCLUSION: The low prevalence of diabetic retinopathy in these Down's syndrome patients, despite the long duration, is an interesting finding. It suggests some inherent protective factor against the development of diabetic retinopathy in this patient subgroup.

Entities:  

Mesh:

Year:  1998        PMID: 9640190      PMCID: PMC1722576          DOI: 10.1136/bjo.82.4.407

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

Review 1.  Diabetic retinopathy: a general survey.

Authors:  G W Blankenship; J S Skyler
Journal:  Diabetes Care       Date:  1978 Mar-Apr       Impact factor: 19.112

Review 2.  Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy.

Authors:  E M Kohner; V Patel; S M Rassam
Journal:  Diabetes       Date:  1995-06       Impact factor: 9.461

3.  Retinal artery pressure in asymmetric diabetic retinopathy.

Authors:  A J Gay; A L Rosenbaum
Journal:  Arch Ophthalmol       Date:  1966-06

4.  Normalized growth velocity in children with Down's syndrome during growth hormone therapy.

Authors:  G Annerén; J Gustafsson; V R Sara; T Tuvemo
Journal:  J Intellect Disabil Res       Date:  1993-08

5.  The Santa Barbara County diabetic retinopathy screening feasibility study: significance of diabetes duration and systolic blood pressure.

Authors:  J M Lewis; L Jovanovic-Peterson; I Ahmadizadeh; W Bevier; C M Peterson; B Williams
Journal:  J Diabetes Complications       Date:  1994 Jan-Mar       Impact factor: 2.852

6.  The role of growth hormone in the development of diabetic retinopathy.

Authors:  A A Alzaid; S F Dinneen; L J Melton; R A Rizza
Journal:  Diabetes Care       Date:  1994-06       Impact factor: 19.112

7.  Growth hormone deficiency in Down's syndrome children.

Authors:  S Castells; C Torrado; W Bastian; K E Wisniewski
Journal:  J Intellect Disabil Res       Date:  1992-02

8.  Retinal blood flow in diabetic retinopathy.

Authors:  V Patel; S Rassam; R Newsom; J Wiek; E Kohner
Journal:  BMJ       Date:  1992-09-19

9.  Blood pressure and retinopathy in type I diabetes.

Authors:  H P Chase; S K Garg; W E Jackson; M A Thomas; S Harris; G Marshall; M J Crews
Journal:  Ophthalmology       Date:  1990-02       Impact factor: 12.079

10.  High systolic blood pressure increases prevalence and severity of retinopathy in NIDDM patients.

Authors:  M Cignarelli; M L De Cicco; A Damato; A Paternostro; S Pagliarini; S Santoro; L Cardia; G De Pergola; R Giorgino
Journal:  Diabetes Care       Date:  1992-08       Impact factor: 19.112

View more
  6 in total

1.  Survival and morbidity outcomes for very low birth weight infants with Down syndrome.

Authors:  Nansi S Boghossian; Nellie I Hansen; Edward F Bell; Barbara J Stoll; Jeffrey C Murray; Abbot R Laptook; Seetha Shankaran; Michele C Walsh; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

2.  Down's syndrome in diabetic patients aged <20 years: an analysis of metabolic status, glycaemic control and autoimmunity in comparison with type 1 diabetes.

Authors:  T R Rohrer; P Hennes; A Thon; A Dost; M Grabert; B Rami; S Wiegand; R W Holl
Journal:  Diabetologia       Date:  2010-02-26       Impact factor: 10.122

3.  Tumor angiogenesis: insights and innovations.

Authors:  Fernando Nussenbaum; Ira M Herman
Journal:  J Oncol       Date:  2010-04-26       Impact factor: 4.375

4.  Impairment of circulating endothelial progenitors in Down syndrome.

Authors:  Valerio Costa; Linda Sommese; Amelia Casamassimi; Roberta Colicchio; Claudia Angelini; Valentina Marchesano; Lara Milone; Bartolomeo Farzati; Alfonso Giovane; Carmela Fiorito; Monica Rienzo; Marco Picardi; Bice Avallone; Massimiliano Marco Corsi; Berardo Sarubbi; Raffaele Calabrò; Paola Salvatore; Alfredo Ciccodicola; Claudio Napoli
Journal:  BMC Med Genomics       Date:  2010-09-13       Impact factor: 3.063

Review 5.  Moyamoya Syndrome: A Window of Moyamoya Disease.

Authors:  Ji Hoon Phi; Kyu-Chang Wang; Ji Yeoun Lee; Seung-Ki Kim
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

6.  Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.

Authors:  Kwan-Hyuck Baek; Alexander Zaslavsky; Ryan C Lynch; Carmella Britt; Yoshiaki Okada; Richard J Siarey; M William Lensch; In-Hyun Park; Sam S Yoon; Takashi Minami; Julie R Korenberg; Judah Folkman; George Q Daley; William C Aird; Zygmunt Galdzicki; Sandra Ryeom
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.